Nonadrenergic inhibitory nervous system in human airways

Area of Science:

• Respiratory Physiology
• Neuropharmacology
• Smooth Muscle Biology

Background:

• Human airways contain complex neural control mechanisms influencing smooth muscle tone.
• Previous research suggested potential inhibitory pathways, but their nature remained unclear.

Purpose of the Study:

• To investigate the presence and characteristics of inhibitory nerves in human airway smooth muscle.
• To determine the role of non-adrenergic and adrenergic systems in airway relaxation.

Main Methods:

• In vitro study of human tracheal and bronchial tissues obtained from surgical resections and autopsies.
• Electrical field stimulation (EFS) of tissues to assess nerve-mediated responses.
• Pharmacological blockade using atropine (cholinergic antagonist) and adrenergic blocking agents.
• Assessment of tetrodotoxin's effect on EFS-induced relaxation.

Main Results:

• EFS revealed cholinergic excitatory nerves, blocked by atropine.
• In the presence of atropine, EFS induced smooth muscle relaxation, even when contracted by histamine.
• This relaxation was unaffected by adrenergic blockers, indicating a non-adrenergic inhibitory system.
• Tetrodotoxin blocked EFS-induced relaxation, confirming nerve involvement.
• No evidence of adrenergic inhibitory fibers was found.

Conclusions:

• The non-adrenergic inhibitory system is the principal inhibitory pathway for human airway smooth muscle.
• This system shares characteristics with similar systems in the gastrointestinal tract and guinea pig trachealis.
• Defects in this airway inhibitory system could underlie hyperreactive airway diseases such as asthma and chronic bronchitis.